Inhibition of miR-92a increases endothelial proliferation and migration in vitro as well as reduces neointimal proliferation in vivo after vascular injury - PubMed (original) (raw)
Inhibition of miR-92a increases endothelial proliferation and migration in vitro as well as reduces neointimal proliferation in vivo after vascular injury
Claudio Iaconetti et al. Basic Res Cardiol. 2012 Sep.
Abstract
The role of miR-92a on vascular remodelling after injury is currently unknown. Thus, the aim of the present study was to evaluate the role of miR-92a on rat endothelial and vascular smooth muscle cells proliferation and migration in vitro as well as after balloon injury or arterial stenting in vivo. MiR-92a was highly expressed in RAO-ECs and vascular endothelium, but not in RAO-SMCs or medial smooth muscle as assessed by real-time RT-PCR. Importantly, BrdU incorporation and wound healing assay provide evidence that functional inhibition of miR-92a resulted in an increased RAO-ECs proliferation and migration, but had no effect on RAO-SMCs proliferation or migration in vitro. Immunoblotting analysis revealed an increased phosphorylation of ERK1/2, JNK/SAPK as well as eNOS and phospho-eNOS increased expression level in RAO-ECs as a consequence of miR-92a inhibition. Using gain and loss of function experiments, we showed that miR-92a modulates regulation of KLF4 and MKK4 expression level in endothelial cells. Finally, in vivo administration of antagomiR-92a significantly enhanced re-endothelialization in injured carotid arteries and reduced neointimal formation after balloon injury or arterial stenting. These data provide the first evidence that inhibition of miR-92a may represent a novel strategy to improve endothelial regeneration and reduce restenosis after vascular injury.
Similar articles
- Inhibition of miR-92a improves re-endothelialization and prevents neointima formation following vascular injury.
Daniel JM, Penzkofer D, Teske R, Dutzmann J, Koch A, Bielenberg W, Bonauer A, Boon RA, Fischer A, Bauersachs J, van Rooij E, Dimmeler S, Sedding DG. Daniel JM, et al. Cardiovasc Res. 2014 Sep 1;103(4):564-72. doi: 10.1093/cvr/cvu162. Epub 2014 Jun 27. Cardiovasc Res. 2014. PMID: 25020912 Free PMC article. - Sunitinib, a small-molecule receptor tyrosine kinase inhibitor, suppresses neointimal hyperplasia in balloon-injured rat carotid artery.
Ishii S, Okamoto Y, Katsumata H, Egawa S, Yamanaka D, Fukushima M, Minami S. Ishii S, et al. J Cardiovasc Pharmacol Ther. 2013 Jul;18(4):359-66. doi: 10.1177/1074248412472258. Epub 2013 Jan 15. J Cardiovasc Pharmacol Ther. 2013. PMID: 23324994 - Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation.
Daniel JM, Prock A, Dutzmann J, Sonnenschein K, Thum T, Bauersachs J, Sedding DG. Daniel JM, et al. Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):317-27. doi: 10.1161/ATVBAHA.115.305974. Epub 2015 Dec 10. Arterioscler Thromb Vasc Biol. 2016. PMID: 26663397 - Biological responses in stented arteries.
Chaabane C, Otsuka F, Virmani R, Bochaton-Piallat ML. Chaabane C, et al. Cardiovasc Res. 2013 Jul 15;99(2):353-63. doi: 10.1093/cvr/cvt115. Epub 2013 May 10. Cardiovasc Res. 2013. PMID: 23667187 Review. - Static and Flow Conditions: Endothelial Cell Migration onto Metal Stent Surfaces.
Sprague E, Luo J, Palmaz JC. Sprague E, et al. J Long Term Eff Med Implants. 2017;27(2-4):97-110. doi: 10.1615/JLongTermEffMedImplants.v27.i2-4.10. J Long Term Eff Med Implants. 2017. PMID: 29773034 Review.
Cited by
- MicroRNA-mediated mechanisms of the cellular stress response in atherosclerosis.
Schober A, Nazari-Jahantigh M, Weber C. Schober A, et al. Nat Rev Cardiol. 2015 Jun;12(6):361-74. doi: 10.1038/nrcardio.2015.38. Epub 2015 Apr 7. Nat Rev Cardiol. 2015. PMID: 25855604 Review. - Transcription Factors Targeted by miRNAs Regulating Smooth Muscle Cell Growth and Intimal Thickening after Vascular Injury.
Khachigian LM. Khachigian LM. Int J Mol Sci. 2019 Oct 31;20(21):5445. doi: 10.3390/ijms20215445. Int J Mol Sci. 2019. PMID: 31683712 Free PMC article. Review. - Electrostatically assembled wound dressings deliver pro-angiogenic anti-miRs preferentially to endothelial cells.
Berger AG, Deiss-Yehiely E, Vo C, McCoy MG, Almofty S, Feinberg MW, Hammond PT. Berger AG, et al. Biomaterials. 2023 Sep;300:122188. doi: 10.1016/j.biomaterials.2023.122188. Epub 2023 Jun 12. Biomaterials. 2023. PMID: 37329684 Free PMC article. - Circulating miR-92a expression level in patients with essential hypertension: a potential marker of atherosclerosis.
Huang Y, Tang S, Ji-Yan C, Huang C, Li J, Cai AP, Feng YQ. Huang Y, et al. J Hum Hypertens. 2017 Mar;31(3):200-205. doi: 10.1038/jhh.2016.66. Epub 2016 Sep 15. J Hum Hypertens. 2017. PMID: 27629245 - Targeting and delivery of microRNA-targeting antisense oligonucleotides in cardiovascular diseases.
Saenz-Pipaon G, Dichek DA. Saenz-Pipaon G, et al. Atherosclerosis. 2023 Jun;374:44-54. doi: 10.1016/j.atherosclerosis.2022.12.003. Epub 2022 Dec 19. Atherosclerosis. 2023. PMID: 36577600 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous